News Focus
News Focus
icon url

Stocker1981

01/22/11 12:58 PM

#3532 RE: buckyboy #3531

Is the 180ish because of dilution or completion of the merger?

With the close of the merger, Stem Cell Therapy International will have approximately 176 million common shares outstanding, which includes the approximately 13 million shares that will be issued five days after the announcement of this merger.